Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 1

-Article 5

Name:	us-gaap_SalesRevenueNet
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Legal Proceedings (Details) (USD $)	3 Months Ended
Legal Proceedings (Details) (USD $)	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2013 Medical Products [Member]	Mar. 31, 2012 Medical Products [Member]	Mar. 31, 2013 Medical/Surgical Dealer [Member] Medical Products [Member]	Mar. 31, 2012 Medical/Surgical Dealer [Member] Medical Products [Member]	Apr. 30, 2013 Subsequent Event [Member]
Loss Contingencies [Line Items]
Net sales	$ 5,691,181	$ 6,068,379	$ 1,361,000	$ 1,447,000	$ 617,000	$ 790,000
Percentage of revenue	90.00%
Accounts Receivable, From Major Customer in Bankruptcy Court, Pre-Petition							$ 240,000